Abstract
Clinical grading systems that use clinical characteristics, as well as nomograms, do not have the accuracy to guide treatment decisions for prostate cancer (prostate cancer). There is a critical need to identify biomarkers that can more accurately stratify men with primary prostate cancer

This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
